Home > Formulary : Paediatric > Recent Decisions > 2023 >
Decisions 17th October 2023
New Drug Requests:
Approved
Actimorph (morphine sulfate orodispersible tablets) (TLS Amber Specialist Recommended)
- pain relief
Aklief® (trifarotene cream 50micrograms/g) (TLS Green)
- treatment of acne
Other decisions and discussions:
- Morphine TLS changed from Green to Amber Specialist Recommended
- Tramadol TLS changed from Green to Amber Specialist Recommended
- Folinic acid (calcium folinate) for metabolic disorders - TLS changed from Red to Amber Specialist Recommended
- ADHD SCPs for methylphenidate, lisdexamfetamine and atomoxetine approved
- Ketorolac injection - TLS to change to Red on all formulary chapters.
- ADHD medicines shortage discussed.
- Adex gel emollient - not approved for treatment of eczema, psoriasis and dermatitis.
- Doublebase Once emollient - not approved for treatment of eczema, psoriasis and dermatitis.
Cardiovascular Chapter Review and Update
Decisions include:
- Lipid lowering drugs - TLS to change to Amber Specialist Initiated for some lipid lowering drugs
- Enoxaparin - TLS to be changed to Red for all patients
- Nadalol, propranolol, carvedilol, metoprolol, nadolol, atenolol, amlodipine, nifedipine, diltiazem, verapamil, captopril, enalapril, lisinopril,losartan, irbesartan,spironolactone,furosemide- change TLS to Amber Specialist Initiated
- Hydralazine, sotalol, verapamil, - change TLS to Amber 1 month when a SCP has been developed and approved
- Taurolock, alteplase and streptokinase to be added as TLS Red
- Adrenaline and noradrenaline to be added as TLS Red (inotrope for Heart Failure)
- valsartan- remove (not used)
- Digoxin, aspirin, warfarin, flecainide, -TLS to change Amber Specialist Initiated
- Clopidogrel- further work needed